Interferon and Ribavirin Combination Treatment Synergistically Inhibit HCV Internal Ribosome Entry Site Mediated Translation at the Level of Polyribosome Formation

PURPOSE: Although chronic hepatitis C virus (HCV) infection has been treated with the combination of interferon alpha (IFN-α) and ribavirin (RBV) for over a decade, the mechanism of antiviral synergy is not well understood. We aimed to determine the synergistic antiviral mechanisms of IFN-α and RBV...

Descripción completa

Detalles Bibliográficos
Autores principales: Panigrahi, Rajesh, Hazari, Sidhartha, Chandra, Sruti, Chandra, Partha K., Datta, Sibnarayan, Kurt, Ramazan, Cameron, Craig E., Huang, Zhuhui, Zhang, Haitao, Garry, Robert F., Balart, Luis A., Dash, Srikanta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751885/
https://www.ncbi.nlm.nih.gov/pubmed/24009705
http://dx.doi.org/10.1371/journal.pone.0072791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751885/
https://www.ncbi.nlm.nih.gov/pubmed/24009705
http://dx.doi.org/10.1371/journal.pone.0072791

Ejemplares similares